AIFA updates the Transparency Lists

Asset Publisher

AIFA updates the Transparency Lists

AIFA has published the updated Transparency Lists of generic medicines together with the related reference prices, updated at 15 May 2024.

Published on: 15 May 2024

Asset Publisher

Site Map

Pricing and reimbursement

Share

Nested Applications

Highlights

09/10/2025 - Medicines approved for reimbursement by the AIFA Board of Directors. These include two new molecules, three generics, three biosimilars and an extension of therapeutic indication

23/09/2025 - Use of paracetamol during pregnancy: European recommendations confirmed

ALL NEWS

News

23/10/2025

EMA confirms suspension of sickle cell disease medicine Oxbryta

20/10/2025

Hepatitis C: update of 20 October 2025 concerning enrolled patients

15/10/2025

The AIFA Activity Report Is Now Online

All news

Galleria

Nested Applications

Press

Medicines approved for reimbursement by the AIFA Board of Directors. These include two new molecules, three generics, three biosimilars and an extension of therapeutic indication

All press releases

Last tweets

🤝 Incontro istituzionale tra il Presidente di #AIFA Robert Nisticò e il Capo dell’Autorità Egiziana...

Vai al post →

🤝 Ad Amsterdam l’incontro istituzionale tra #AIFA e Taiwan FDA. 📚 Durante il Summit 2025 della Co...

Vai al post →

Ciprofloxacina, levofloxacina, moxifloxacina: nomi forse poco familiari, ma che indicano una classe ...

Vai al post →

📊 Online il Rapporto AIFA 2024 La pubblicazione presenta i dati e le attività principali del 2024 a...

Vai al post →

🎗 #13ottobre - Questa sera #AIFA si illumina di rosa per la Giornata nazionale di sensibilizzazione...

Vai al post →

🌍 #AIFA si illumina per la Giornata Mondiale PANS/PANDAS 2025 e aderisce alla campagna globale #Lig...

Aifa toggle bar Search

Aifa toggle bar Search